FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to a liquid stable pharmaceutical composition suitable for administration by inhalation, comprising: (i) particles of ensifentrine, (ii) glycopyrrolate and (iii) a diluent, and said diluent contains water, wherein the glycopyrrolate is dissolved in the diluent, the glycopyrrolate concentration is less than or equal to 5.0 mg/ml, and the pH of the liquid pharmaceutical composition ranges from 3.0 to 6.0.
EFFECT: liquid pharmaceutical composition containing ensifentrine and glycopyrrolate.
20 cl, 3 tbl, 2 ex
Authors
Dates
2024-12-05—Published
2021-02-26—Filed